Seizure and Cognitive Outcomes in Children and Adolescents with Epilepsy Treated with Topiramate

Abstract

This 12-week open label study explored cognitive and seizure outcomes of 53 children treated with topiramate (TPM). The digit symbol test and verbal learning memory test were administered at baseline and study endpoint. Topiramate was started either in monotherapy or add-on therapy. Overall, 57% of children experienced a ≥50% seizure reduction, 36% became seizure free and cognitive testing revealed no significant changes during TPM therapy. Due to the heterogeneity of the study population, post hoc analyses were added to compare patients in initial or conversion to TPM monotherapy as well as patients who continued add-on therapy. Verbal learning memory test parameters showed neither significant differences within any subgroup comparing baseline with endpoint nor significant differences between described subgroups except for one finding. The digit symbol test revealed no differences between each subgroup between baseline and endpoint. Comparing pre-post differences, TPM monotherapy was associated with better cognitive outcomes than treatment in add-on therapy. These results have to be interpreted with caution given the short study duration and the heterogeneity of the study population. Despite these limitations, our overall results suggest that treatment with topiramate is associated with improved seizure control without significant changes in cognitive functions at the low doses tested.

Key words

topiramate - anticonvulsant therapy - epilepsy, cognition - digit symbol test (HAWIK-III) - memory - children - adolescents

References

• 1 Aldenkamp AP, Arends J, Verspeek S. et al . The cognitive impact of epileptiform EEG-discharges; relationship with type of cognitive task.  Child Neuropsychol. 2004;  10 297-305
• 2 Aldenkamp AP, Baker G, Mulder OG. et al . A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures.  Epilepsia. 2000;  41 1167-1178
• 3 Aldenkamp AP, de KM, Reijs R. Newer antiepileptic drugs and cognitive issues.  Epilepsia. 2003;  44 (S 04) 21-29 :21–29
• 4 Aldenkamp AP, Vermeulen J. Phenytoin and carbamazepine: differential effects on cognitive function.  Seizure. 1995;  4 95-104
• 5 Aldenkamp AP, Weber B, Overweg-Plandsoen WC. et al . Educational underachievement in children with epilepsy: a model to predict the effects of epilepsy on educational achievement.  J Child Neurol. 2005;  20 175-180
• 6 Arroyo S, Boothman BR, Brodie MJ. et al . A randomised open-label study of tiagabine given two or three times daily in refractory epilepsy.  Seizure. 2005;  14 81-84
• 7 Donati F, Gobbi G, Campistol J. et al . Effects of oxcarbazepine on cognitive function in children and adolescents with partial seizures.  Neurology. 2006;  67 679-682
• 8 Donati F, Gobbi G, Campistol J. et al . The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures.  Seizure. 2007;  16 670-679
• 9 Elterman RD, Glauser TA, Wyllie E. et al . A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group.  Neurology. 1999;  52 1338-1344
• 10 Glauser TA, Levisohn PM, Ritter F. et al . Topiramate in Lennox-Gastaut syndrome: open-label treatment of patients completing a randomized controlled trial. Topiramate YL Study Group.  Epilepsia. 2000;  41 (S 01) S86-S90
• 11 Hermann B, Jones J, Dabbs K. et al . The frequency, complications and aetiology of ADHD in new onset paediatric epilepsy.  Brain. 2007;  130 3135-3148
• 12 Hermann B, Jones J, Sheth R. et al . Children with new-onset epilepsy: neuropsychological status and brain structure.  Brain. 2006;  129 2609-2619
• 13 Hitiris N, Mohanraj R, Norrie J. et al . Predictors of pharmacoresistant epilepsy.  Epilepsy Res. 2007;  75 192-196
• 14 Kang HC, Eun BL, Wu LC. et al . The effects on cognitive function and behavioral problems of topiramate compared to carbamazepine as monotherapy for children with benign rolandic epilepsy.  Epilepsia. 2007;  48 1716-1723
• 15 Kaufman A, Kaufman N, Melchers P. et al .Kaufman Assessment Battery for Children, Deutsche Version – Individual-test zur Messung von Intelligenz und Fertigkeit bei Kindern. Leiden: PITS; 2001
• 16 Loring DW, Meador KJ. Cognitive side effects of antiepileptic drugs in children.  Neurology. 2004;  62 872-877
• 17 Martin R, Kuzniecky R, Ho S. et al . Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.  Neurology. 1999;  52 321-327
• 18 Meador KJ, Loring DW, Hulihan JF. et al . Differential cognitive and behavioral effects of topiramate and valproate.  Neurology. 2003;  60 1483-1488
• 19 Nicolai J, Aldenkamp AP, Arends J. et al . Cognitive and behavioral effects of nocturnal epileptiform discharges in children with benign childhood epilepsy with centrotemporal spikes.  Epilepsy Behav. 2006;  8 56-70
• 20 Ritter F, Glauser TA, Elterman RD. et al . Effectiveness, tolerability, and safety of topiramate in children with partial-onset seizures. Topiramate YP Study Group.  Epilepsia. 2000;  41 (S 01) S82-S85
• 21 Seidenberg M, Pulsipher DT, Hermann B. Cognitive progression in epilepsy.  Neuropsychol Rev. 2007;  17 445-454
• 22 Shannon HE, Eberle EL, Peters SC. Comparison of the effects of anticonvulsant drugs with diverse mechanisms of action in the formalin test in rats.  Neuropharmacology. 2005;  48 1012-1020
• 23 Smith ME, Gevins A, McEvoy LK. et al . Distinct cognitive neurophysiologic profiles for lamotrigine and topiramate.  Epilepsia. 2006;  47 695-703
• 24 Tatum WO, French JA, Faught E. et al . Postmarketing experience with topiramate and cognition.  Epilepsia. 2001;  42 1134-1140
• 25 Tewes U, Rossmann P, Schallberger U. Hamburg–Wechsler-Intelligenztest für Kinder HAWIK-III. Bern: Huber; 1999
• 26 Tonekaboni SH, Beyraghi N, Tahbaz HS. et al . Neurocognitive effects of phenobarbital discontinuation in epileptic children.  Epilepsy Behav. 2006;  8 145-148
• 27 Trimble MR, Thompson PJ. Memory, anticonvulsant drugs and seizures.  Acta Neurol Scand Suppl. 1981;  89 31-41
• 28 Vermeulen J, Aldenkamp AP. Cognitive side-effects of chronic antiepileptic drug treatment: a review of 25 years of research.  Epilepsy Res. 1995;  22 65-95

Correspondence